Repetitive Transcranial Magnetic Stimulation With and Without Internet-Delivered Cognitive-Behavioral Therapy for the Treatment of Resistant Depression: Protocol for Patient-Centered Randomized Controlled Pilot Trial

Rabab M Abou El-Magd, Gloria Obuobi-Donkor, Medard K Adu, Christopher Lachowski, Surekha Duddumpudi, Mobolaji A Lawal, Adegboyega O Sapara, Michael Achor, Maryam Kouzehgaran, Roshan Hegde, Corina Chew, Mike Mach, Shelley Daubert, Liana Urichuk, Mark Snaterse, Shireen Surood, Daniel Li, Andrew Greenshaw, Vincent Israel Opoku Agyapong, Rabab M Abou El-Magd, Gloria Obuobi-Donkor, Medard K Adu, Christopher Lachowski, Surekha Duddumpudi, Mobolaji A Lawal, Adegboyega O Sapara, Michael Achor, Maryam Kouzehgaran, Roshan Hegde, Corina Chew, Mike Mach, Shelley Daubert, Liana Urichuk, Mark Snaterse, Shireen Surood, Daniel Li, Andrew Greenshaw, Vincent Israel Opoku Agyapong

Abstract

Background: Major depression is a severe, disabling, and potentially lethal clinical disorder. Only about half of patients respond to an initial course of antidepressant pharmacotherapy. At least 15% of all patients with major depressive disorder (MDD) remain refractory to any treatment intervention. By the time that a patient has experienced 3 definitive treatment failures, the likelihood of achieving remission with the fourth treatment option offered is below 10%. Repetitive transcranial magnetic stimulation (rTMS) is considered a treatment option for patients with MDD who are refractory to antidepressant treatment. It is not currently known if the addition of internet-delivered cognitive-behavioral therapy (iCBT) enhances patients' responses to rTMS treatments.

Objective: This study will evaluate the initial comparative clinical effectiveness of rTMS with and without iCBT as an innovative patient-centered intervention for the treatment of participants diagnosed with treatment-resistant depression (TRD).

Methods: This study is a prospective, two-arm randomized controlled trial. In total, 100 participants diagnosed with resistant depression at a psychiatric care clinic in Edmonton, Alberta, Canada, will be randomized to one of two conditions: (1) enrolment in rTMS sessions alone and (2) enrolment in the rTMS sessions plus iCBT. Participants in each group will complete evaluation measures (eg, recovery, general symptomatology, and functional outcomes) at baseline, 1 month, 3 months, and 6 months. The primary outcome measure will be the mean change to scores on the Hamilton Depression Rating Scale. Patient service utilization data and clinician-rated measures will also be used to gauge patient progress. Patient data will be analyzed with descriptive statistics, repeated measures, and correlational analyses.

Results: We expect the results of the study to be available in 24 months. We hypothesize that participants enrolled in the study who receive rTMS plus iCBT will achieve superior outcomes in comparison to participants who receive rTMS alone.

Conclusions: The concomitant application of psychotherapy with rTMS has not been investigated previously. We hope that this project will provide us with a concrete base of data to evaluate the practical application and efficacy of using a novel combination of these two treatment modalities (rTMS plus iCBT).

Trial registration: ClinicalTrials.gov NCT0423965; https://ichgcp.net/clinical-trials-registry/NCT04239651.

International registered report identifier (irrid): PRR1-10.2196/18843.

Keywords: cognitive-behavioral therapy; depression; internet-delivered cognitive-behavioral therapy; repetitive transcranial magnetic stimulation; treatment of resistant depression.

Conflict of interest statement

Conflicts of Interest: None declared.

©Rabab M Abou El-Magd, Gloria Obuobi-Donkor, Medard K Adu, Christopher Lachowski, Surekha Duddumpudi, Mobolaji A Lawal, Adegboyega O Sapara, Michael Achor, Maryam Kouzehgaran, Roshan Hegde, Corina Chew, Mike Mach, Shelley Daubert, Liana Urichuk, Mark Snaterse, Shireen Surood, Daniel Li, Andrew Greenshaw, Vincent Israel Opoku Agyapong. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 27.10.2020.

References

    1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National CSR. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003 Jun 18;289(23):3095–105. doi: 10.1001/jama.289.23.3095.
    1. Murray CA, Lopez AD. Geneva, Switzerland: WJO; 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020; p. A.
    1. American Foundation for Suicide Prevention . Mental health conditions and suicide. American Foundation for Suicide Prevention; 2009. [2019-12-11]. You are not alone. .
    1. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62 Suppl 16:10–7.
    1. Rush AJ, Thase ME, Dubé S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003 Apr 15;53(8):743–53. doi: 10.1016/s0006-3223(03)00088-x.
    1. Greden JF. Unmet need: what justifies the search for a new antidepressant? J Clin Psychiatry. 2002;63 Suppl 2:3–7.
    1. Papakostas GI. Tolerability of modern antidepressants. J Clin Psychiatry. 2008;69 Suppl E1:8–13.
    1. Leon AC, Solomon DA, Mueller TI, Endicott J, Rice JP, Maser JD, Coryell W, Keller MB. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry. 2003 Apr;160(4):727–33. doi: 10.1176/appi.ajp.160.4.727.
    1. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996 Aug;153(8):985–92. doi: 10.1176/ajp.153.8.985.
    1. Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006 Sep;163(9):1519–30; quiz 1665. doi: 10.1176/ajp.2006.163.9.1519.
    1. Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry. 2006 Jul;163(7):1161–72. doi: 10.1176/appi.ajp.163.7.1161.
    1. McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry. 2006 Sep;163(9):1531–41; quiz 1666. doi: 10.1176/ajp.2006.163.9.1531.
    1. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR* DT. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006 Jan;163(1):28–40. doi: 10.1176/appi.ajp.163.1.28.
    1. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M, STAR*D Study Team Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006 Mar 23;354(12):1231–42. doi: 10.1056/NEJMoa052963.
    1. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ, STAR*D Study Team Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006 Mar 23;354(12):1243–52. doi: 10.1056/NEJMoa052964.
    1. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905–17. doi: 10.1176/appi.ajp.163.11.1905.
    1. Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song W, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, CANMAT Depression Work Group Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care. Can J Psychiatry. 2016 Sep;61(9):510–23. doi: 10.1177/0706743716659416.
    1. Lal S, Adair CE. E-mental health: a rapid review of the literature. Psychiatr Serv. 2014 Jan 1;65(1):24–32. doi: 10.1176/appi.ps.201300009.
    1. Karasouli E, Adams A. Assessing the Evidence for e-Resources for Mental Health Self-Management: A Systematic Literature Review. JMIR Ment Health. 2014;1(1):e3. doi: 10.2196/mental.3708.
    1. Grist R, Porter J, Stallard P. Mental Health Mobile Apps for Preadolescents and Adolescents: A Systematic Review. J Med Internet Res. 2017 May 25;19(5):e176. doi: 10.2196/jmir.7332.
    1. Andrews G, Basu A, Cuijpers P, Craske MG, McEvoy P, English CL, Newby JM. Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: An updated meta-analysis. J Anxiety Disord. 2018 Apr;55:70–78. doi: 10.1016/j.janxdis.2018.01.001.
    1. Arnberg FK, Linton SJ, Hultcrantz M, Heintz E, Jonsson U. Internet-delivered psychological treatments for mood and anxiety disorders: a systematic review of their efficacy, safety, and cost-effectiveness. PLoS One. 2014;9(5):e98118. doi: 10.1371/journal.pone.0098118.
    1. Vallury KD, Jones M, Oosterbroek C. Computerized Cognitive Behavior Therapy for Anxiety and Depression in Rural Areas: A Systematic Review. J Med Internet Res. 2015;17(6):e139. doi: 10.2196/jmir.4145.
    1. Titov N. Internet-delivered psychotherapy for depression in adults. Curr Opin Psychiatry. 2011 Jan;24(1):18–23. doi: 10.1097/YCO.0b013e32833ed18f.
    1. Richards D, Richardson T. Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev. 2012 Jun;32(4):329–42. doi: 10.1016/j.cpr.2012.02.004.
    1. Eells TD, Barrett MS, Wright JH, Thase M. Computer-assisted cognitive-behavior therapy for depression. Psychotherapy (Chic) 2014 Jun;51(2):191–7. doi: 10.1037/a0032406.
    1. Renton T, Tang H, Ennis N, Cusimano MD, Bhalerao S, Schweizer TA, Topolovec-Vranic J. Web-based intervention programs for depression: a scoping review and evaluation. J Med Internet Res. 2014;16(9):e209. doi: 10.2196/jmir.3147.
    1. Holländare F, Anthony SA, Randestad M, Tillfors M, Carlbring P, Andersson G, Engström I. Two-year outcome of internet-based relapse prevention for partially remitted depression. Behav Res Ther. 2013 Nov;51(11):719–22. doi: 10.1016/j.brat.2013.08.002.
    1. Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical Guidelines for the Management of Major Depressive Disorder in Adults. I. Classification, Burden and Principles of Management. Journal of Affective Disorders. 2009 Oct;117:S5–S14. doi: 10.1016/j.jad.2009.06.044.
    1. Patten SB. Updated CANMAT Guidelines for Treatment of Major Depressive Disorder. Can J Psychiatry. 2016 Sep;61(9):504–5. doi: 10.1177/0706743716660034.
    1. Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Ravindran AV, Uher R, CANMAT Depression Work Group Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Can J Psychiatry. 2016 Dec;61(9):524–39. doi: 10.1177/0706743716659418.
    1. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R, CANMAT Depression Work Group Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016 Sep;61(9):540–60. doi: 10.1177/0706743716659417.
    1. Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, Modirrousta M, Patry S, Vila-Rodriguez F, Lam RW, MacQueen GM, Parikh SV, Ravindran AV, CANMAT Depression Work Group Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry. 2016 Sep;61(9):561–75. doi: 10.1177/0706743716660033.
    1. Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Parikh SV, CANMAT Depression Work Group Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Can J Psychiatry. 2016 Sep;61(9):576–87. doi: 10.1177/0706743716660290.
    1. MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJV, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV, CANMAT Depression Work Group Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Can J Psychiatry. 2016 Sep;61(9):588–603. doi: 10.1177/0706743716659276.
    1. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007 Jul 19;55(2):187–99. doi: 10.1016/j.neuron.2007.06.026.
    1. Noda Y, Silverstein WK, Barr MS, Vila-Rodriguez F, Downar J, Rajji TK, Fitzgerald PB, Mulsant BH, Vigod SN, Daskalakis ZJ, Blumberger DM. Neurobiological mechanisms of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in depression: a systematic review. Psychol Med. 2015 Dec;45(16):3411–32. doi: 10.1017/S0033291715001609.
    1. Galletly C, Gill S, Clarke P, Burton C, Fitzgerald PB. A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: is efficacy related to the duration of treatment or the number of treatments? Psychol Med. 2012 May;42(5):981–8. doi: 10.1017/S0033291711001760.
    1. McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MPA, Berlim MT. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial. J Affect Disord. 2015 Mar 01;173:216–20. doi: 10.1016/j.jad.2014.10.068.
    1. George MS, Raman R, Benedek DM, Pelic CG, Grammer GG, Stokes KT, Schmidt M, Spiegel C, Dealmeida N, Beaver KL, Borckardt JJ, Sun X, Jain S, Stein MB. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients. Brain Stimul. 2014;7(3):421–31. doi: 10.1016/j.brs.2014.03.006.
    1. McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov;28(11):973–80. doi: 10.1002/da.20885.
    1. Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012 Jul;29(7):587–96. doi: 10.1002/da.21969.
    1. Kedzior KK, Azorina V, Reitz SK. More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013. Neuropsychiatr Dis Treat. 2014;10:727–56. doi: 10.2147/NDT.S58405. doi: 10.2147/NDT.S58405.
    1. Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014 Jan;44(2):225–39. doi: 10.1017/S0033291713000512.
    1. Hovington CL, McGirr A, Lepage M, Berlim MT. Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses. Ann Med. 2013 Jun;45(4):308–21. doi: 10.3109/07853890.2013.783993.
    1. Leggett LE, Soril LJJ, Coward S, Lorenzetti DL, MacKean G, Clement FM. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord. 2015;17(6) doi: 10.4088/PCC.15r01807.
    1. Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, Jonas DE, Swinson Evans T, Viswanathan M, Lohr KN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014 May;75(5):477–89; quiz 489. doi: 10.4088/JCP.13r08815.
    1. Health Quality Ontario Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ont Health Technol Assess Ser. 2016;16(5):1–66.
    1. Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology. 2013 Mar;38(4):543–51. doi: 10.1038/npp.2012.237. doi: 10.1038/npp.2012.237.
    1. Cohen RB, Boggio PS, Fregni F. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety. 2009;26(7):682–8. doi: 10.1002/da.20486.
    1. Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014 Dec;75(12):1394–401. doi: 10.4088/JCP.13m08977.
    1. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct;3(4):187–99. doi: 10.1016/j.brs.2010.07.003.
    1. Richieri R, Guedj E, Michel P, Loundou A, Auquier P, Lançon C, Boyer L. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord. 2013 Oct;151(1):129–35. doi: 10.1016/j.jad.2013.05.062.
    1. Fitzgerald PB, Grace N, Hoy KE, Bailey M, Daskalakis ZJ. An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul. 2013 May;6(3):292–7. doi: 10.1016/j.brs.2012.05.003.
    1. Hazlett‐Stevens H, Craske MG. Brief cognitive-behavioral therapy: definition and scientific foundations. In: Bond FW, Craske MG, editors. Handbook of Brief Cognitive Behaviour Therapy. Hoboken, NJ, USA: John Wiley & Sons; 2002.
    1. Gratzer D, Khalid-Khan F. Internet-delivered cognitive behavioural therapy in the treatment of psychiatric illness. CMAJ. 2016 Mar 01;188(4):263–72. doi: 10.1503/cmaj.150007.
    1. Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2015;3:CD011565. doi: 10.1002/14651858.CD011565.
    1. Haldane D. MoodGYM. 2006. [2020-09-11]. .
    1. Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J. A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technol Assess. 2002;6(22):1–89.
    1. Kaltenthaler E, Brazier J, De NE, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess. 2006 Sep;10(33):iii, xi–xiv, 1.
    1. Kaltenthaler E, Parry G, Beverley C. Computerized Cognitive Behaviour Therapy: A Systematic Review. Behav Cogn Psychother. 2004 Feb 18;32(1):31–55. doi: 10.1017/s135246580400102x.
    1. Kaltenthaler E, Parry G, Beverley C, Ferriter M. Computerised cognitive-behavioural therapy for depression: systematic review. Br J Psychiatry. 2008 Sep;193(3):181–4. doi: 10.1192/bjp.bp.106.025981.
    1. Spek V, Cuijpers P, Nyklícek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med. 2007 Mar;37(3):319–28. doi: 10.1017/S0033291706008944.
    1. Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196–205. doi: 10.1080/16506070903318960.
    1. Griffiths K, Christensen H. Review of randomised controlled trials of Internet interventions for mental disorders and related conditions. Clinical Psychologist. 2006;10:16–29. doi: 10.1080/13284200500378696.
    1. Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials. Med J Aust. 2010 Jun 7;192(11 Suppl):S4–11.
    1. Wade AG. Use of the internet to assist in the treatment of depression and anxiety: a systematic review. Prim Care Companion J Clin Psychiatry. 2010 Aug;12(4) doi: 10.4088/PCC.09r00876blu.
    1. Pospos S, Young IT, Downs N, Iglewicz A, Depp C, Chen JY, Newton I, Lee K, Light GA, Zisook S. Web-Based Tools and Mobile Applications To Mitigate Burnout, Depression, and Suicidality Among Healthcare Students and Professionals: a Systematic Review. Acad Psychiatry. 2017 Dec 18;42(1):109–120. doi: 10.1007/s40596-017-0868-0.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33.
    1. Haynes R, Guyatt G, Tugwell P. Clinical epidemiology: how to do clinical practice research. Philadelphia PA: Lippincott, Williams, Wilkins; 2005. 78174524 pp.
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62.
    1. Carroll BJ, Fielding JM, Blashki TG. Depression rating scales. A critical review. Arch Gen Psychiatry. 1973 Mar;28(3):361–6. doi: 10.1001/archpsyc.1973.01750330049009.
    1. Posner K, Brent D, Lucas C, Gould M, Stanley B, Brown G, Fisher P, Zelazny J, Burke A, Oquendo M, Mann J. Columbia-suicide severity rating scale (C-SSRS) New York, NY, USA: Columbia University Medical Center; 2008.
    1. Shahid A, Wilkinson K, Marcu S, Shapiro C. STOP, THAT and One Hundred Other Sleep Scales. New York, NY, USA: Springer; 2011. Columbia-Suicide Severity Rating Scale (C-SSRS) pp. 131–35.
    1. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978 Nov;133:429–35. doi: 10.1192/bjp.133.5.429. doi: 10.1192/bjp.133.5.429.
    1. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003 Sep 01;54(5):573–83.
    1. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA, STARD Investigators Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006 Mar;12(2):71–9. doi: 10.1097/00131746-200603000-00002.
    1. Rush A, Asberg M. Patient Rated Inventory of Side Effects (PRISE) Dallas, TX, USA: University of Texas; 1999. Unpublished rating scale.
    1. Szende A, Williams A. Measuring self-reported population health: An international perspective based on EQ-5D. 2004. [2020-10-16]. .
    1. Brooks R, Rabin R, De Charro F. The measurement and valuation of health status using EQ-5D: a European perspective. Evidence from the EuroQol BIOMED Research Programme. New York, NY, USA: Springer Science & Business Media; 2013.
    1. Ustün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C, WHO/NIH Joint Project Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010 Nov 01;88(11):815–23. doi: 10.2471/BLT.09.067231.
    1. IBM Corp IBM SPSS Statistics for Macintosh, Version 26.0. [2020-10-16]. .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe